TriLogic Pharma CSO to present TRI-726 at drug delivery conference
September 19 , 2011

TriLogic Pharma’s Chief Scientific Officer, Hemant H. Alur, PhD, MBA, will be speaking at the Partnership Opportunities in Drug Delivery conference to be held October 4-5, 2011, in Boston, MA. The Conference is a strategic level event on emerging and enabling technologies designed with the following purposes: 1. To present pharma and biotech business development and external licensing professionals with a thorough overview of the latest drug delivery technologies available along with an update on deals and opportunities to enhance patients’ quality of life, improve therapies and extend the life cycle of a drug. 2. To provide drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights from both established pharma and biotechs as well as start-up companies on what the delivery and formulation needs are. Dr. Alur will present TriLogic Pharma’s proprietary drug delivery platform, TRI-726.